Metabolon provides an end‑to‑end metabolomics service that combines ultra‑high‑performance mass spectrometry profiling of over 4,000 metabolites with a cloud‑based analytics platform. The solution delivers quantitative data, curated annotations, and statistical analyses through an interactive web portal, supporting biomarker discovery, drug development, and precision medicine for pharma, biotech, academic, and clinical researchers.
Funding
$7.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Researchers and clinicians often lack comprehensive, high‑throughput metabolomic data and integrated analysis tools needed to identify biomarkers, understand disease mechanisms, and support drug development. Traditional metabolomics workflows are fragmented, require specialized equipment, and generate data that are difficult to interpret without advanced bioinformatics support.
Solution
Metabolon offers an end‑to‑end metabolomics platform that combines large‑scale mass spectrometry profiling with a cloud‑based analytics suite. The service generates quantitative metabolite measurements across thousands of compounds from diverse biological samples, then applies curated databases and statistical pipelines to deliver actionable insights. Users can access results through an interactive web portal that supports multi‑omics integration, longitudinal studies, and custom reporting. Metabolon also provides consulting, assay development, and educational resources such as webinars and case studies to help customers translate metabolomic data into research or clinical outcomes.
Target Audience
Primary customers are pharmaceutical and biotech companies, academic and clinical research laboratories, and healthcare organizations seeking metabolomic profiling and data interpretation for biomarker discovery, drug development, and precision medicine.
Features
- High‑throughput ultra‑high‑performance mass spectrometry covering >4,000 metabolites across multiple biofluid and tissue types
- Cloud‑based data processing pipeline with built‑in quality control, normalization, and statistical analysis
- Interactive web dashboard for data visualization, multi‑omics integration, and export of results in standard formats
- Extensive reference library of curated metabolite annotations, pathways, and disease associations
- Custom assay development, study design consulting, and regulatory‑compliant reporting services
- Educational resources including webinars, videos, case studies, and a searchable publication repository